GE HealthCare Technologies Inc.

(GEHC)

CIK 1932393 · SEC filings only

Not gradedDividend record
shown as history
company entity
8 dividend record entries

Dividend record — shown as history, not graded

A declared dividend is a reported fact, not a promise we grade. Here's the record — raises, holds, and cuts — each linked to its source filing.

Dividend record

8 declarations · 1 raised · 3 held · 0 cut · held 4 quarters

  1. NOTED$0.0350/shperiod ended 2026-03-31Filing ↗
  2. NOTED$0.0700/shperiod ended 2025-09-30Filing ↗
  3. RAISED$0.0350/shperiod ended 2025-03-31Filing ↗
  4. HELD$0.0300/shperiod ended 2024-09-30Filing ↗
  5. HELD$0.0300/shperiod ended 2024-06-30Filing ↗
  6. HELD$0.0300/shperiod ended 2024-03-31Filing ↗
  7. NOTED$0.0300/shperiod ended 2023-09-30Filing ↗
  8. INITIATED$0.0600/shperiod ended 2023-06-30Filing ↗
Descriptive dividend record — every entry links to its source filing. Not graded (a declared dividend is a reported fact, not a promise). Full methodology →
Not yet gradedGuidance record
harness minimum not met
company entity
0 resolved promises

Not enough GAAP-comparable guidance to grade

0 of the 4 resolved guidance promises needed to publish a reliability grade. Much of this company’s guidance is non-GAAP, which has no comparable GAAP actual in SEC XBRL to check it against — shown below, never scored. Here's what we're tracking — we never show a grade we can't back with receipts.

Pro

guidance history

Free scorecards show the 12 most recent resolved guidance promises. See the complete multi-year record with Pro.

See Pro

Guidance shown, not graded (2)

These are non-GAAP forecasts. There is no comparable GAAP figure in SEC XBRL to check them against, so we show what was said — with its source filing — but never score it.

  1. eps guidance q · Jul 23, 2026
    The Company expects to report year-over-year growth in diluted EPS and Adjusted EPS*
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗
  2. revenue guidance fy · Jan 10, 2023
    Organic revenue growth* in the range of 5% to 7% year over year.
    Unverifiable — company guides non-GAAP; no comparable GAAP actual exists in XBRL.Filing ↗

Open promises (1)

Open · revenue guidance q

GE HealthCare expects to report year-over-year Revenue growth of 5.7%

resolves in ~20 daysreceipt
0 resolved guidance promises · 2dropped (couldn't be resolved on a consistent basis) · resolver resolver-v3 · score score-v1. Every verdict links to its source filing. Full methodology →